Federated Hermes’s Gyre Therapeutics GYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12.1K Buy
+1,648
New +$11K ﹤0.01% 1809
2018
Q4
– Sell
-23
Closed -$2K – 2237
2018
Q3
$2K Buy
+23
New +$1.82K ﹤0.01% 2145

Other funds holding GYRE

Federated Hermes's GYRE Position: Q3 2026 in Review

Federated Hermes opened a new position in Gyre Therapeutics (GYRE) in Q3 2026: 1,648 shares worth $12.1K. The stake represents ﹤0.01% of the portfolio and ranks #1809 among its holdings. This is a return to the name: Federated Hermes previously reported a position in GYRE as recently as Q3 2018.

Federated Hermes first reported a position in GYRE in Q3 2018 and has held it in 2 quarters since. 58 funds tracked by Wall St. Rank hold GYRE as of Q3 2026.

  • Federated Hermes held 1,648 shares of Gyre Therapeutics worth $12.1K as of Q3 2026.
  • Gyre Therapeutics was a new Federated Hermes position in Q3 2026.
  • Gyre Therapeutics made up ﹤0.01% of Federated Hermes's portfolio in Q3 2026, its #1809 holding.
  • Federated Hermes first reported a position in Gyre Therapeutics in Q3 2018 and has held it in 2 quarters since.
  • 58 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q3 2026.

Based on Federated Hermes's 13F filing for Q3 2026, filed 12 Nov 2026.